@dinomehic.bsky.social
MD PhD | Physician Scientist at Medical University of Vienna | Thrombosis and Haemostasis | Hematology
🌟 #ECTH2025 is just around the corner! 🌟
Join us in Prague to explore the latest discoveries in #thrombosisandhaemostasis in a beautiful place rich in culture.
🔗 Register here to secure early bird rates: www.ecth.org/registration/
Curious about CzechFunFact #2?
#ECTH2025 #ECTHJAB #CzechFunFacts
So inspiring to see the #ISTHearlycareer leaders play important roles to advance many @isth.org program. Learn more about ISTH #SSC Co-Chairs and their important contributions:
➡️Gael Marrow
➡️@dinomehic.bsky.social
➡️@aaron-iding.bsky.social
➡️Cheryl Maier
Read more here: bit.ly/3XOmNCI
Very interesting data on the role of fibrin film in health and disease by @fibrin-fraser.bsky.social @ GTH2025 in Lausanne
21.02.2025 10:35 — 👍 2 🔁 0 💬 0 📌 0
At this years #GTH2025 in Lausanne everything is about ARTE - advances - research - technology and education!
19.02.2025 07:56 — 👍 2 🔁 0 💬 0 📌 0
Interesting case-report from Germany on a successful treatment of multi-refractory primary immune thrombocytopenia using CD19 CAR T-cell therapy. Could this be a therapeutic option for multi-refractory ITP? www.thelancet.com/journals/lan...
03.01.2025 23:01 — 👍 2 🔁 0 💬 0 📌 0🎄🎄🎄
26.12.2024 20:02 — 👍 1 🔁 0 💬 0 📌 0
Excellent short commentary in the journal Blood about the prospective Austrian study examining bleeding in cancer patients. The rates of bleeding observed were higher than the placebo arms of anticoagulation in cancer studies. #Cancer #bleeding
28.11.2024 19:34 — 👍 6 🔁 2 💬 0 📌 0Did anyone else get excited to see this Late Breaking Clinical Trial appear for #ASH24? Really important data on low- vs. standard-dosing DOACs for long-term treatment of VTE. However, results are complex... will they change practice?
ash.confex.com/ash/2024/web...
